Related Experiment Video
Updated: Jun 22, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
PML-IV functions as a negative regulator of telomerase by interacting with TERT
Wonkyung Oh1, Jaewang Ghim, Eun-Woo Lee
1Department of Biotechnology and Bioengineering, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Korea.
Abstract:
Maintaining proper telomere length requires the presence of the telomerase enzyme. Here we show that telomerase reverse transcriptase (TERT), a catalytic component of telomerase, is recruited to promyelocytic leukemia (PML) nuclear bodies through its interaction with PML-IV. Treatment of interferon-alpha (IFNalpha) in H1299 cells resulted in the increase of PML proteins with a concurrent decrease of telomerase activity, as previously reported. PML depletion, however, stimulated telomerase activity that had been inhibited by IFNalpha with no changes in TERT mRNA levels. Upon treatment with IFNalpha, exogenous TERT localized to PML nuclear bodies and binding between TERT and PML increased. Immunoprecipitation and immunofluorescence analyses showed that TERT specifically bound to PML-IV. Residues 553-633 of the C-terminal region of PML-IV were required for its interaction with the TERT region spanning residues 1-350 and 595-946. The expression of PML-IV and its deletion mutant, 553-633, suppressed intrinsic telomerase activity in H1299. TERT-mediated immunoprecipitation of PML or the 553-633 fragment demonstrated that these interactions inhibited telomerase activity. H1299 cell lines stably expressing PML-IV displayed decreased telomerase activity with no change of TERT mRNA levels. Accordingly, telomere length of PML-IV stable cell lines was shortened. These results indicate that PML-IV is a negative regulator of telomerase in the post-translational state.
Insights
Promyelocytic leukemia protein IV (PML-IV) acts as a negative regulator of telomerase. This interaction, occurring post-translationally, reduces telomerase activity and shortens telomere length, impacting cellular aging.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Telomere length maintenance is crucial for cellular stability and is regulated by the enzyme telomerase.
- Telomerase reverse transcriptase (TERT) is the catalytic subunit of telomerase.
- Promyelocytic leukemia (PML) nuclear bodies are dynamic structures involved in various cellular processes.
Purpose of the Study:
- To investigate the role of PML-IV in the regulation of telomerase activity.
- To elucidate the mechanism by which PML-IV interacts with TERT.
- To determine the effect of PML-IV expression on telomere length.
Main Methods:
- Immunoprecipitation and immunofluorescence assays to analyze protein interactions.
- Expression of PML-IV and its mutants in H1299 cells.
- Measurement of telomerase activity.
- Analysis of telomere length.
Main Results:
- TERT is recruited to PML nuclear bodies via interaction with PML-IV.
- PML-IV directly binds to TERT, specifically involving PML-IV residues 553-633 and TERT residues 1-350 and 595-946.
- Expression of PML-IV suppresses telomerase activity and leads to telomere shortening.
- PML-IV acts as a negative regulator of telomerase in a post-translational manner.
Conclusions:
- PML-IV negatively regulates telomerase activity through a post-translational mechanism.
- The interaction between TERT and PML-IV is critical for inhibiting telomerase function.
- PML-IV plays a significant role in controlling telomere length.
More Related Videos
08:26Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein
Published on: June 12, 2018
10:14Telomerase Activity in the Various Regions of Mouse Brain: Non-Radioactive Telomerase Repeat Amplification Protocol (TRAP) Assay
Published on: September 2, 2014
Related Concept Videos
Abnormal Proliferation
Telomeres and Telomerase
Telomeres and Telomerase
Negative Regulator Molecules
Replicative Cell Senescence
PI3K/mTOR/AKT Signaling Pathway